Dark | Light
# Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics (ARQT) stock surges to a 52-week high, fueled by strong Q3 earnings and anticipation of an FDA decision. Social media buzz and analyst upgrades are amplifying positive sentiment.

### About Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for dermatological conditions.  
Arcutis Biotherapeutics, Inc. uses the ticker $ARQT for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Arcutis Biotherapeutics, Inc. (ARQT) social dominance is up 165% from the previous week.
- Arcutis Biotherapeutics, Inc. (ARQT) Galaxy Scoreβ„’ is up 80% from the previous week.

### Price: $25.90
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/close.tsv)  
The stock price has seen a significant surge, reaching a 52-week high, driven by strong Q3 earnings, positive revenue growth, and the anticipation of an FDA decision for a topical foam treatment. High social media engagement and positive sentiment, including analyst upgrades, are further supporting this upward trend.  

24-Hour: -2.66%
7-Day: -5.34%
30-Day: 0.04%

1-Year High: $31.20 on 2025-12-05  
1-Year Low: $12.20 on 2025-02-25  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/alt_rank.tsv)  
Arcutis Biotherapeutics, Inc. (ARQT) is currently AltRank #1,624 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +195  
[--] Month: [-----] +347  
[--] Months: [-----] +1,238  
[--] Year: [-----] +1,259  
1-Year High: [-----] on 2026-02-13  
1-Year Low: [--] on 2025-12-13  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +16  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-04-21  
1-Year Low: [--] on 2025-09-25  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [------]  
[--] Week: [-----] -47%  
[--] Month: [------] -82%  
[--] Months: [---------] -46%  
[--] Year: [---------] -18%  
1-Year High: [-------] on 2025-10-28  
1-Year Low: [---] on 2026-02-13  

Engagements by network (24h):
YouTube: [--]
Reddit: [--]
X: [---]
TikTok: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] -12%  
[--] Month: [---] +33%  
[--] Months: [-----] -15%  
[--] Year: [-----] -20%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-09-21  

Mentions by network (24h):
YouTube: [--]
Reddit: [--]
X: [--]
TikTok: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Arcutis Biotherapeutics, Inc. (ARQT) in the last [--] hours which is up 16% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] -5.10%  
[--] Month: [---] +52%  
[--] Months: [---] -39%  
[--] Year: [-----] +147%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-09-21  

The most influential creators that mention Arcutis Biotherapeutics, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BPharmCatalyst](/creator/twitter/BPharmCatalyst)   | [--]    | [------]    | [--]     | [--]          |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [--]          |
| [@BIOTECHSCANNER](/creator/twitter/BIOTECHSCANNER)   | [--]    | [-----]     | [--]     | [--]           |
| [@avinash_redekar](/creator/twitter/avinash_redekar) | [--]    | [------]    | [--]     | [--]           |
| [@tradeandfade](/creator/twitter/tradeandfade)       | [--]    | [-----]     | [--]     | [--]           |
| [@tenet_research](/creator/twitter/tenet_research)   | [--]    | [-------]   | [--]     | [--]           |
| [@MarketMaestro1](/creator/twitter/MarketMaestro1)   | [--]    | [------]    | [--]     | [--]           |

[View More](/list/creators/$arqt/100)
  
  
### Sentiment: 93%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/sentiment.tsv)  
Current Value: 93%  
Daily Average: 89%  
[--] Week: 75% -25%  
[--] Month: 75% +1%  
[--] Months: 75% -17%  
[--] Year: 75% -19%  
1-Year High: 100% on 2025-02-22  
1-Year Low: 33% on 2025-04-01  

Most Supportive Themes:
- Positive Q3 Earnings and Revenue: (30%) Arcutis Biotherapeutics reported a profitable third quarter with revenue significantly exceeding expectations, driven by strong Zoryve sales.
- FDA Decision Catalyst: (25%) An upcoming FDA decision for a topical foam treatment for psoriasis is viewed as a significant catalyst for the company.
- Analyst Upgrades and Price Target Increases: (20%) Multiple analysts have raised their price targets for ARQT, with Goldman Sachs maintaining a Neutral rating and Mizuho raising their target significantly.
  
Most Critical Themes:
- Neutral Analyst Rating: (15%) Despite positive Q3 results and revenue growth, Goldman Sachs maintains a 'Neutral' rating, suggesting a balanced outlook from this key analyst.
  
  
  
### Social Dominance: 0.00422%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/social_dominance.tsv)  
Current Value: 0.00422%  
Daily Average: 0.00989%  
[--] Week: 0.00371% +0.00231%  
[--] Month: 0.013% +0.0067%  
[--] Months: 0.013% +0.0024%  
[--] Year: 0.013% no change  
1-Year High: 0.034% on 2025-06-29  
1-Year Low: 0.0019% on 2025-09-21  
  
  
### Market Dominance: 0.00359%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/market_dominance.tsv)  
Current Value: 0.00359%  
Daily Average: 0%  
1-Year High: 0.155% on 2026-02-06  
1-Year Low: 0.00359% on 2026-02-14  
  
  
### Market Cap: $3,167,648,085
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$arqt/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$arqt/time-series/market_cap.tsv)  
Current Value: $3,167,648,085  
Daily Average: $3,307,548,701  
[--] Week: $3,184,796,992 -4.80%  
[--] Month: $3,167,648,085 -1.90%  
1-Year High: $3,821,756,390 on 2025-12-05  
1-Year Low: $2,405,746,651 on 2025-10-27  

### Top Arcutis Biotherapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"This caught my attention $LYEL $FATE $ALLO $CRBU $ADPT $PSNL $BNR $NTRA $TWST $GH $EXAS $NVTA $PSNL $BNR $NTRA $TWST $GH $EXAS $NVTA $ZNTL $EOLS $PTCT $VKTX $MCRB $JANX $NKTX $CARM $FHTX $KURA $VOR $MRUS $RCKT $ARQT $SANA $DYN $FULC πŸ›‘ Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie Operating Co. is building something BIG in the DJ Basin πŸ’₯ Explosive revenue EBITDA & production growth πŸ’₯ Oil-weighted assets = stronger margins in a rising crude environment πŸ’₯ Strategic acquisitions adding https://t.co/nFWsHPltVX πŸ›‘ Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie Operating"  
[X Link](https://x.com/shabeezy84/status/2022352920516120985) [@shabeezy84](/creator/x/shabeezy84) 2026-02-13T16:51Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics (ARQT) stock surges to a 52-week high, fueled by strong Q3 earnings and anticipation of an FDA decision. Social media buzz and analyst upgrades are amplifying positive sentiment.

About Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for dermatological conditions.
Arcutis Biotherapeutics, Inc. uses the ticker $ARQT for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Arcutis Biotherapeutics, Inc. (ARQT) social dominance is up 165% from the previous week.
  • Arcutis Biotherapeutics, Inc. (ARQT) Galaxy Scoreβ„’ is up 80% from the previous week.

Price: $25.90

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price has seen a significant surge, reaching a 52-week high, driven by strong Q3 earnings, positive revenue growth, and the anticipation of an FDA decision for a topical foam treatment. High social media engagement and positive sentiment, including analyst upgrades, are further supporting this upward trend.

24-Hour: -2.66% 7-Day: -5.34% 30-Day: 0.04%

1-Year High: $31.20 on 2025-12-05
1-Year Low: $12.20 on 2025-02-25

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Arcutis Biotherapeutics, Inc. (ARQT) is currently AltRank #1,624 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] +195
[--] Month: [-----] +347
[--] Months: [-----] +1,238
[--] Year: [-----] +1,259
1-Year High: [-----] on 2026-02-13
1-Year Low: [--] on 2025-12-13

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +16
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-04-21
1-Year Low: [--] on 2025-09-25

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [------]
[--] Week: [-----] -47%
[--] Month: [------] -82%
[--] Months: [---------] -46%
[--] Year: [---------] -18%
1-Year High: [-------] on 2025-10-28
1-Year Low: [---] on 2026-02-13

Engagements by network (24h): YouTube: [--] Reddit: [--] X: [---] TikTok: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] -12%
[--] Month: [---] +33%
[--] Months: [-----] -15%
[--] Year: [-----] -20%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-09-21

Mentions by network (24h): YouTube: [--] Reddit: [--] X: [--] TikTok: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Arcutis Biotherapeutics, Inc. (ARQT) in the last [--] hours which is up 16% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [---] -5.10%
[--] Month: [---] +52%
[--] Months: [---] -39%
[--] Year: [-----] +147%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-09-21

The most influential creators that mention Arcutis Biotherapeutics, Inc. in the last [--] hours

Creator Rank Followers Posts Engagements
@BPharmCatalyst [--] [------] [--] [--]
@NightOwlBiotech [--] [-----] [--] [--]
@BIOTECHSCANNER [--] [-----] [--] [--]
@avinash_redekar [--] [------] [--] [--]
@tradeandfade [--] [-----] [--] [--]
@tenet_research [--] [-------] [--] [--]
@MarketMaestro1 [--] [------] [--] [--]

View More

Sentiment: 93%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 93%
Daily Average: 89%
[--] Week: 75% -25%
[--] Month: 75% +1%
[--] Months: 75% -17%
[--] Year: 75% -19%
1-Year High: 100% on 2025-02-22
1-Year Low: 33% on 2025-04-01

Most Supportive Themes:

  • Positive Q3 Earnings and Revenue: (30%) Arcutis Biotherapeutics reported a profitable third quarter with revenue significantly exceeding expectations, driven by strong Zoryve sales.
  • FDA Decision Catalyst: (25%) An upcoming FDA decision for a topical foam treatment for psoriasis is viewed as a significant catalyst for the company.
  • Analyst Upgrades and Price Target Increases: (20%) Multiple analysts have raised their price targets for ARQT, with Goldman Sachs maintaining a Neutral rating and Mizuho raising their target significantly.

Most Critical Themes:

  • Neutral Analyst Rating: (15%) Despite positive Q3 results and revenue growth, Goldman Sachs maintains a 'Neutral' rating, suggesting a balanced outlook from this key analyst.

Social Dominance: 0.00422%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00422%
Daily Average: 0.00989%
[--] Week: 0.00371% +0.00231%
[--] Month: 0.013% +0.0067%
[--] Months: 0.013% +0.0024%
[--] Year: 0.013% no change
1-Year High: 0.034% on 2025-06-29
1-Year Low: 0.0019% on 2025-09-21

Market Dominance: 0.00359%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00359%
Daily Average: 0%
1-Year High: 0.155% on 2026-02-06
1-Year Low: 0.00359% on 2026-02-14

Market Cap: $3,167,648,085

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $3,167,648,085
Daily Average: $3,307,548,701
[--] Week: $3,184,796,992 -4.80%
[--] Month: $3,167,648,085 -1.90%
1-Year High: $3,821,756,390 on 2025-12-05
1-Year Low: $2,405,746,651 on 2025-10-27

Top Arcutis Biotherapeutics, Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"This caught my attention $LYEL $FATE $ALLO $CRBU $ADPT $PSNL $BNR $NTRA $TWST $GH $EXAS $NVTA $PSNL $BNR $NTRA $TWST $GH $EXAS $NVTA $ZNTL $EOLS $PTCT $VKTX $MCRB $JANX $NKTX $CARM $FHTX $KURA $VOR $MRUS $RCKT $ARQT $SANA $DYN $FULC πŸ›‘ Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie Operating Co. is building something BIG in the DJ Basin πŸ’₯ Explosive revenue EBITDA & production growth πŸ’₯ Oil-weighted assets = stronger margins in a rising crude environment πŸ’₯ Strategic acquisitions adding https://t.co/nFWsHPltVX πŸ›‘ Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie Operating"
X Link @shabeezy84 2026-02-13T16:51Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Arcutis Biotherapeutics, Inc. (ARQT)
/topic/$arqt